12/23/2024 10:51 AM
Eli Lilly and Co (NYSE:LLY) is in focus today, after the U.S. Food & Drug Administration (FDA) approved its weight-loss drug, Zepbound, to treat obstructive sleep apnea in adults with obesity -- the f...
6/6/2023 2:56 PM
Medical equipment name ResMed Inc (NYSE:RMD) is looking to snap a four-day win streak, down 0.3% at $221.33 at last glance. The stock is grappling with its 20-day moving average, but still sports a 6....
1/23/2018 1:42 PM
Shares of ResMed Inc. (NYSE:RMD) -- a medical device company specializing in sleep apnea -- are exploding higher today, thanks to well-received fiscal second-quarter earnings and a subsequent round...